The latest news for pharma industry insiders.
Author - David Miller
MDMA Therapy for Mental Health Conditions: Do the Benefits...
Despite a recent FDA Complete Response Letter issued to Lykos for midomafetamine capsules for the...
Merck Acquires Modifi Biosciences
Merck is acquiring the Yale-spinout, which develops direct DNA modification-enabled cancer...
Fake Weight Loss Drugs: Growing Threat to Consumer Health
In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder...
Report: Radiopharmaceutical Market Expected to Reach $26.51...
Growth is expected due to increased instances of chronic diseases such as cancer and Alzheimer...
FDA Approves AbbVie Therapy for Adults with Advanced...
Vyalev, also known as Produodopa, has been approved in 35 countries, with more than 4200 patients...
AbbVie, Gedeon Richter Ink Deal to Develop Novel Targets for...
Under terms of the deal, Richter will receive an upfront cash payment of $25 million, along with...
Strengthening Regulatory Framework for Compounded Medications
Scott Brunner, CEO, and Tenille Davis, Chief Advocacy Officer, of the Alliance for Pharmacy...
CPHI Milan 2024: Highlighting the Benefits of Integrated Services
Pharmaceutical Technology Europe chats with Kevin Li, MBA, from BioDuro-Sundia about integrated...
BioDuro-Sundia Opens New Kilogram Laboratory at Shanghai Site
The laboratory is on the same site as BioDuro-Sundia’s new Compound Management Center, which was...